Guenther, Rita S.

To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an uninterrupted supply of quality-assured (QA), second-line anti-TB drugs (SLDs) is necessary. Patients diagnosed …

Developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculos…: workshop summary

by Nicholson, Anna, English, Rebecca A., Guenther, Rita S., Claiborne, Anne B., Institute of Medicine (U.S.)., Forum on Drug Discovery, Development, and Translation, Workshop on Global Drug Supply Chain for Secondline Anti-tuberculosis Drugs, Washington, D.C.)

0 Type: Book

To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an uninterrupted supply of quality-assured (QA), second-line anti-TB drugs (SLDs) is necessary. Patients diagnosed …

Developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculos…: workshop summary

by Nicholson, Anna, English, Rebecca A., Guenther, Rita S., Claiborne, Anne B., Institute of Medicine (U.S.)., Forum on Drug Discovery, Development, and Translation, Workshop on Global Drug Supply Chain for Secondline Anti-tuberculosis Drugs, Washington, D.C.)

0 Type: Book

To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an uninterrupted supply of quality-assured (QA), second-line anti-TB drugs (SLDs) is necessary. Patients diagnosed …